Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
4.07 (USD) • At close May 23, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||||
| Current Assets: | |||||||||||||||||||
| Cash & Cash Equivalents
| 500.453 | 594.35 | 427.647 | 476.124 | 299.521 | 394.796 | 387.322 | 405.87 | 473.145 | 549.912 | 454.646 | 453.875 | 507.891 | 285.116 | 394.721 | 632.738 | 214.088 | 262.126 | -69.883 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61.561 | 83.214 | 231.446 | 184.189 | 0 | 0 | 0 | 139.766 |
| Cash and Short Term Investments
| 500.453 | 594.35 | 427.647 | 476.124 | 299.521 | 394.796 | 387.322 | 405.87 | 473.145 | 549.912 | 454.646 | 515.436 | 591.105 | 516.562 | 578.91 | 632.738 | 214.088 | 262.126 | 69.883 |
| Net Receivables
| 46.124 | 49.166 | 2.255 | 2.526 | 2.599 | 3.094 | 3.164 | 3.051 | 2.057 | 2.753 | 11.635 | 11.68 | 11.397 | 9.09 | 2.282 | 0.049 | 0.071 | 0.156 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 2.256 | 3.325 | 1.311 | 1.28 | 2.09 | 1.901 | 1.521 | 1.552 | 10.233 | 10.232 | 5.042 | 5.041 | 0 |
| Other Current Assets
| 37.568 | 70.753 | 44.27 | 45.508 | 41.495 | 43.478 | 20.036 | 22.099 | 16.923 | 17.149 | 15.337 | 18.88 | 16.953 | 9.066 | 19.678 | 14.848 | 7.663 | 4.155 | 0 |
| Total Current Assets
| 584.145 | 714.269 | 474.172 | 522.375 | 343.615 | 438.137 | 410.522 | 431.02 | 492.125 | 569.814 | 481.618 | 545.996 | 619.455 | 534.718 | 600.87 | 647.635 | 221.822 | 269.478 | 69.883 |
| Non-Current Assets: | |||||||||||||||||||
| Property, Plant & Equipment, Net
| 204.777 | 233.213 | 159.189 | 156.283 | 122.217 | 120.173 | 120.31 | 124.667 | 125.12 | 121.447 | 119.503 | 116.151 | 104.005 | 64.725 | 55.439 | 48.549 | 44.642 | 25.967 | 0 |
| Goodwill
| 158.112 | 148.873 | 52.056 | 52.056 | 52.056 | 52.056 | 52.75 | 60.516 | 0.801 | 0.801 | 0.801 | 0.801 | 0.801 | 0.801 | 0.801 | 0.801 | 0.801 | 0.801 | 0 |
| Intangible Assets
| 335.79 | 335.855 | 34.093 | 38.21 | 33.076 | 36.443 | 39.459 | 42.757 | 1.318 | 1.306 | 1.457 | 1.233 | 1.309 | 1.385 | 1.461 | 2.338 | 2.414 | 2.49 | 0 |
| Goodwill and Intangible Assets
| 493.902 | 484.728 | 86.149 | 90.266 | 85.132 | 88.499 | 92.209 | 103.273 | 2.119 | 2.107 | 2.258 | 2.034 | 2.11 | 2.186 | 2.262 | 2.338 | 2.414 | 2.49 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 6.629 | 6.629 | 6.629 | 7.629 | 7.629 | 7.92 | 7.92 | 8.154 | 8.334 | 8.713 | 8.681 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 2.003 | 1.934 | 0 | 0 | 0 | 36.443 | -7.629 | -7.629 | -7.92 | -7.92 | -8.154 | -8.334 | -8.713 | -8.681 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 20.407 | 14.454 | 6.989 | 0.308 | 0.254 | -36.182 | 7.784 | 7.739 | 8.002 | 7.92 | 8.154 | 8.334 | 0.036 | 0.035 | 0.035 | 0.068 | 3.065 | 0.65 | -69.883 |
| Total Non-Current Assets
| 721.089 | 734.329 | 252.327 | 253.486 | 214.232 | 215.562 | 220.303 | 235.679 | 135.241 | 131.474 | 129.915 | 126.519 | 114.864 | 75.627 | 57.736 | 50.955 | 50.121 | 29.107 | -69.883 |
| Total Assets
| 1,305.234 | 1,448.598 | 726.499 | 775.861 | 557.847 | 653.699 | 630.825 | 666.699 | 627.366 | 701.288 | 611.533 | 672.515 | 734.319 | 610.345 | 658.606 | 698.59 | 271.943 | 298.585 | 0 |
| Liabilities & Equity: | |||||||||||||||||||
| Current Liabilities: | |||||||||||||||||||
| Account Payables
| 25.086 | 21.613 | 2.26 | 3.762 | 5.115 | 3.953 | 4.265 | 2.086 | 4.247 | 4.586 | 3.89 | 3.176 | 4.162 | 2.819 | 6.326 | 3.196 | 3.125 | 1.074 | 0 |
| Short Term Debt
| 20.44 | 22.22 | 16.452 | 25.323 | 6.117 | 12.273 | 11.405 | 11.114 | 9.541 | 6.049 | 11.177 | 10.577 | 8.264 | 1.506 | 2.92 | 3.634 | 2.644 | 1.54 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.278 | 0 |
| Deferred Revenue
| 39.651 | 61.767 | 49.579 | 32.204 | 36.618 | 36.426 | 43.997 | 73.105 | 57.761 | 56.726 | 46.753 | 63.781 | 54.247 | 10 | 10 | 10 | 10 | 10 | 0 |
| Other Current Liabilities
| 56.804 | 81.872 | 40.597 | 24.794 | 26.07 | 40.519 | 34.451 | 27.654 | 20.601 | 32.904 | 21.216 | 19.119 | 19.032 | 32.333 | 25.113 | 12.71 | 11.085 | 20.207 | 0 |
| Total Current Liabilities
| 141.981 | 187.472 | 108.888 | 86.083 | 73.92 | 93.171 | 94.118 | 113.959 | 92.15 | 100.265 | 83.036 | 96.653 | 85.705 | 46.658 | 42.943 | 29.54 | 26.854 | 23.099 | 0 |
| Non-Current Liabilities: | |||||||||||||||||||
| Long Term Debt
| 72.47 | 86.272 | 74.173 | 73.16 | 44.857 | 44.515 | 45.426 | 47.005 | 47.95 | 44.956 | 46.554 | 48.349 | 47.927 | 9.972 | 4.116 | 11.85 | 12.891 | 14.122 | 0 |
| Deferred Revenue Non-Current
| 0 | 118.765 | 0 | 29.169 | 37.391 | 51.238 | 51.383 | 32.436 | 57.091 | 70.261 | 93.909 | 89.934 | 107.121 | 6.667 | 9.167 | 11.667 | 14.167 | 16.667 | 0 |
| Deferred Tax Liabilities Non-Current
| 22.437 | 16.575 | 0.168 | 21.07 | 0.528 | 1.339 | 1.931 | 4.336 | 1.179 | 0.536 | 0.561 | 0.586 | -107.121 | 0 | 4.547 | -6.687 | -11.289 | -18.175 | 0 |
| Other Non-Current Liabilities
| 134.399 | 4.732 | 18.711 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.11 | 3.348 | 2.819 | 2.75 | 450.986 | 0 |
| Total Non-Current Liabilities
| 229.306 | 226.344 | 93.052 | 105.329 | 82.776 | 97.092 | 98.74 | 83.777 | 105.041 | 115.217 | 140.463 | 138.283 | 155.048 | 20.749 | 16.631 | 26.336 | 478.12 | 481.775 | 0 |
| Total Liabilities
| 371.287 | 413.816 | 201.94 | 191.412 | 156.696 | 190.263 | 192.858 | 197.736 | 197.191 | 215.482 | 223.499 | 234.936 | 240.753 | 67.407 | 59.574 | 55.876 | 504.974 | 504.874 | 0 |
| Equity: | |||||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 658.606 | 698.59 | 448.312 | 448.312 | 201.109 |
| Common Stock
| 0.004 | 0.004 | 0.003 | 0.003 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0 | 0 | 0 |
| Retained Earnings
| -1,633.694 | -1,431.283 | -1,252.377 | -1,156.535 | -1,058.995 | -967.622 | -874.626 | -781.609 | -704.883 | -639.556 | -582.064 | -521.619 | -456.059 | -400.08 | -335.147 | -287.719 | -244.318 | -213.601 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 14.145 | -7.637 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | -0.197 | -0.309 | -0.126 | 0.002 | -698.59 | 0 | 0 | -124.265 |
| Other Total Stockholders Equity
| 2,553.492 | 2,473.698 | 1,776.933 | 1,740.981 | 1,460.144 | 1,431.056 | 1,312.591 | 1,250.57 | 1,135.056 | 1,125.36 | 970.096 | 959.393 | 949.932 | 943.142 | 934.175 | 231.841 | 11.287 | -441 | 0 |
| Total Shareholders Equity
| 933.947 | 1,034.782 | 524.559 | 584.449 | 401.151 | 463.436 | 437.967 | 468.963 | 430.175 | 485.806 | 388.034 | 437.579 | 493.566 | 542.938 | 599.032 | 642.714 | -233.031 | -206.289 | 76.844 |
| Total Equity
| 933.947 | 1,034.782 | 524.559 | 584.449 | 401.151 | 463.436 | 437.967 | 468.963 | 430.175 | 485.806 | 388.034 | 437.579 | 493.566 | 542.938 | 599.032 | 642.714 | -233.031 | -206.289 | 76.844 |
| Total Liabilities & Shareholders Equity
| 1,305.234 | 1,448.598 | 726.499 | 775.861 | 557.847 | 653.699 | 630.825 | 666.699 | 627.366 | 701.288 | 611.533 | 672.515 | 734.319 | 610.345 | 658.606 | 698.59 | 271.943 | 298.585 | 76.844 |